Related references
Note: Only part of the references are listed.UFMylation of RPL26 links translocation-associated quality control to endoplasmic reticulum protein homeostasis
Lihui Wang et al.
CELL RESEARCH (2020)
A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondria! Metabolism and ER-Resident UFMylation
Jin Rui Liang et al.
CELL (2020)
UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination
Jiang Liu et al.
NATURE CELL BIOLOGY (2020)
Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway
Dong-kai Guo et al.
ACTA PHARMACOLOGICA SINICA (2019)
MRE11 UFMylation promotes ATM activation
Zhifeng Wang et al.
NUCLEIC ACIDS RESEARCH (2019)
UFL1 promotes histone H4 ufmylation and ATM activation
Bo Qin et al.
NATURE COMMUNICATIONS (2019)
SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by Which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1
Qianqian Duan et al.
JOURNAL OF PROTEOME RESEARCH (2019)
UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling
Jian-Xian Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
Valentina Gambardella et al.
CLINICAL CANCER RESEARCH (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Ribosomal protein RPL26 is the principal target of UFMylation
Christopher P. Walczak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation
Yafei Cai et al.
CELL DISCOVERY (2019)
AKR1C enzymes sustain therapy resistance in paediatric T-ALL
Roberta Bortolozzi et al.
BRITISH JOURNAL OF CANCER (2018)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Proteomic and Biochemical Analyses Reveal a Novel Mechanism for Promoting Protein Ubiquitination and Degradation by UFBP1, a Key Component of Ufmylation
Ying Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer
Jian-Xian Lin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia
Adetutu T. Egunsola et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Genome-based exome sequencing analysis identifies GYG1, DIS3L and DDRGK1 are associated with myocardial infarction in Koreans
Ji-Young Lee et al.
JOURNAL OF GENETICS (2017)
Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis
Siyu Wang et al.
CELL DEATH & DISEASE (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
Isocoumarin Derivatives from the Sponge-Associated Fungus Peyronellaea glomerata with Antioxidant Activities
Yang Zhao et al.
CHEMISTRY & BIODIVERSITY (2016)
Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target
Evgeny Yakirevich et al.
CLINICAL CANCER RESEARCH (2016)
Parkin represses 6-hydroxydopamine-induced apoptosis via stabilizing scaffold protein p62 in PC12 cells
Xiao-ou Hou et al.
ACTA PHARMACOLOGICA SINICA (2015)
Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils
Sheng-Quan Hu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development
Yafei Cai et al.
PLOS GENETICS (2015)
Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer
Hee Min Yoo et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Whole genome methylation analyses of schizophrenia patients before and after treatment
Blaga Rukova et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2014)
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
Tongde Wu et al.
GENES & DEVELOPMENT (2014)
Modification of ASC1 by UFM1 Is Crucial for ERα Transactivation and Breast Cancer Development
Hee Min Yoo et al.
MOLECULAR CELL (2014)
Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification
Chih-Cheng Chen et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Tatiana Ivanova et al.
GUT (2013)
A Mental Retardation-linked Nonsense Mutation in Cereblon Is Rescued by Proteasome Inhibition
Guoqiang Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
S. Chowdhry et al.
ONCOGENE (2013)
Enhanced 4-Hydroxynonenal Resistance in KEAP1 Silenced Human Colon Cancer Cells
Kyeong-Ah Jung et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
DDRGK1 Regulates NF-κB Activity by Modulating IκBα Stability
Peng Xi et al.
PLOS ONE (2013)
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
HUMAN MOLECULAR GENETICS (2011)
7th Edition of the AJCC Cancer Staging Manual: Stomach
Kay Washington
ANNALS OF SURGICAL ONCOLOGY (2010)
Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
Shinsuke Homma et al.
CLINICAL CANCER RESEARCH (2009)
Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of Nrf2 by cancer chemotherapeutic agents
Xiu Jun Wang et al.
CANCER RESEARCH (2006)
Share Paper
